What's the Next Big Thing in the Contraceptives Market ? Bayer HealthCare AG, Medisafe Distribution Inc, Teva Pharmaceutical Industries Limited, Medicines360

Contraception is deliberate prevention of pregnancy by interfering with normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques. Contraceptives are the drugs or devices which not only inhibit pregnancy but also sexually transmitted diseases (STDs). The contraceptive devices are available in various forms such as coil, loop, triangle, and T-shaped, and are made of plastic or metal. Currently the trend witnessed in the global contraceptive devices market is the development of products such as self-administrative contraceptive injections, vaginal rings, non-surgical permanent contraception devices, sub-dermal contraceptive implants, etc. The contraceptive products are in the market for more than 50 years and are used by 100 million women across the globe. The World Contraception Day was initiated by Bayer Healthcare in coalition with several NGOs as a market strategy and is celebrated on 26th September in order to spread awareness about contraceptives and their benefits.

Contraceptives Market: Key Players

Some of the key players identified in the global contraceptives market are Bayer HealthCare AG, Medisafe Distribution Inc, Teva Pharmaceutical Industries Limited, Medicines360, Pace Pharmaceuticals Inc., Actavis, Inc., Church & Dwight, Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Pfizer, Inc.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1091

Contraceptives Market: Drivers & Restraints

Global contraceptives market is projected to grow rapidly due to increasing public awareness in making right decisions about their sexual and reproductive health. Major drivers for global contraceptives market are technological advancements and an increase in the development of effective female contraceptive drugs and devices. At the same time, increasing government and NGO initiatives to promote contraceptives, implementation of the patient protection act or the affordable care act as well as rising global prevalence of sexually transmitted infections (STI) are fuelling the growth of global contraceptives market. Large number of regulatory approvals of contraceptives, for instance Medicines & Healthcare products Regulatory Agency (MHRA) has authorized self-injection of subcutaneous injectable contraceptives in United Kingdom. This is an example of increasing market opportunity in developed countries. Adoption of new permanent contraceptive practices instead of critical family planning procedures is the major driver especially in low-income countries. The side effects associated with the use of contraceptive drugs and devices and rising prevalence of infertility are the major factors that can hamper the global contraceptives market growth over the forecast period.

Contraceptives Market: Segmentation

The global contraceptives market is classified on the basis of product type, end use and geography.

Based on product type, global contraceptive market is segmented into the following:

Drugs
Contraceptive pills/ Combined hormonal contraceptives (CHCs)
Male contraceptive pills
Female contraceptive pills
Topical contraceptives
Contraceptive injectable
Others (contraceptive gels, jellies and creams)
Medical devices
Male contraceptive devices (Condoms)
Female contraceptive devices
Female Condoms
Intrauterine Devices
Hormonal IUCD
Copper IUCD
Contraceptive Sponges
Contraceptive Diaphragms
Contraceptive Patches
Sub-dermal Contraceptive Implants
Non-Surgical Permanent Contraceptive Devices
Contraceptive Vaginal Rings

Based on end use, the global contraceptive market is segmented into the following:

Hospitals
Home care
Clinics
Ambulatory Surgical Centres

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1091

Contraceptives Market: Overview

In North America, the combined hormonal contraceptives (CHCs) market sub-segment is dominating the overall drugs segment owing to their high usage in preventing pregnancy and convenience of use. By product type, female contraceptive devices is the leading sub-segment due to their low cost, ease of usage and high potential in the prevention of pregnancy as well as sexually transmitted diseases (STDs). The intrauterine devices (IUD) sub-segment held the largest share in the global contraceptive devices market in 2014 due to high usage rates in Europe and China. However, the introduction of other effective female contraception devices such as implanted sub-dermal contraceptives particularly Sino-implant (II), FC2 female condom and non-surgical permanent contraception devices such as Essure, which suits the purchasing preferences of contraceptive users in Asia is expected to witness substantial growth. On the other hand, Asia Pacific is expected to be the most opportunistic region in global contraceptive market through forecast period due to strong economic growth in countries such as India, China, Singapore, Philippines, Australia and others. The approval of self-injection contraceptives by the United Kingdom’s regulatory agency has introduced it to the countries such as South Africa other low-income countries.

ABOUT US:
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Future Market Insights
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com

This release was published on openPR.